Concert Pharmaceuticals, Inc. Stock or Unit Option Plan Expense
Concert Pharmaceuticals, Inc. reported Stock or Unit Option Plan Expense of $200.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2014-05-14
- Concert Pharmaceuticals, Inc. stock or unit option plan expense for the quarter ending 2014-03-31 was $200.00K, a 0.00% change year-over-year.
- Concert Pharmaceuticals, Inc. stock or unit option plan expense for the quarter ending 2013-03-31 was $200.00K.
| Period end | Stock or Unit Option Plan Expense 3 month |
|---|---|
| 2014-03-31 | $200.00K 10-Q · filed 2014-05-14 |
| 2013-03-31 | $200.00K 10-Q · filed 2014-05-14 |